MicroRNA dysregulation in uveal melanoma: A new player enters the game

Oncotarget

Volumn 6, Issue 7, 2015, Pages 4562-4568

  Li, Zheng ^a   Yu, Xin ^a   Shen, Jianxiong ^a   Jiang, Yang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Diagnosis and therapy; MicroRNAs; Oncogene; Tumor suppressor; Uveal melanoma

Indexed keywords

MICRORNA;

APOPTOSIS; ARTICLE; BIOGENESIS; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE PROGRESSION; DOWN REGULATION; EPIGENETICS; HUMAN; MELANOMA CELL; METASTASIS; MICROARRAY ANALYSIS; PHENOTYPE; PROGNOSIS; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE; UPREGULATION; UVEA MELANOMA; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; UVEA TUMOR;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICRORNAS; PROGNOSIS; UVEAL NEOPLASMS;

EID: 84924955878     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2923     Document Type: Article

References (66)

1. Rashid AB, Grossniklaus HE. Clinical, pathologic, and imaging features and biological markers of uveal melanoma. Methods Mol Biol. 2014; 1102:397-425.
2. Yousef YA, Alkilany M. Characterization, treatment, and outcome of uveal melanoma in the first two years of life. Hematol Oncol Stem Cell Ther. 2014; [Epub ahead of print].
3. Yonekawa Y, Kim IK. Epidemiology and management of uveal melanoma. Hematol Oncol Clin North Am. 2012; 26: 1169-1184.
4. Blanco PL, Lim LA, Miyamoto C, Burnier MN. Uveal melanoma dormancy: an acceptable clinical endpoint? Melanoma Res. 2012; 22:334-340.
5. Schoenfield L. Uveal melanoma: A pathologist's perspective and review of translational developments. Advances in anatomic pathology. 2014; 21:138-143.
6. Gill HS, Char DH. Uveal melanoma prognostication: from lesion size and cell type to molecular class. Can J Ophthalmol. 2012; 47:246-253.
7. Luke JJ, Callahan MK, Postow MA, Romano E, Ramaiya N, Bluth M, Giobbie-Hurder A, Lawrence DP, Ibrahim N, Ott PA, Flaherty KT, Sullivan RJ, Harding JJ, D'Angelo S, Dickson M, Schwartz GK, et al. Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience. Cancer. 2013; 119:3687-3695.
8. Pereira PR, Odashiro AN, Lim LA, Miyamoto C, Blanco PL, Odashiro M, Maloney S, De Souza DF, Burnier MN Jr. Current and emerging treatment options for uveal melanoma. Clin Ophthalmol. 2013; 7:1669-1682.
9. Eschelman DJ, Gonsalves CF, Sato T. Transhepatic therapies for metastatic uveal melanoma. Semin Intervent Radiol. 2013; 30:39-48.
10. Buder K, Gesierich A, Gelbrich G, Goebeler M. Systemic treatment of metastatic uveal melanoma: review of litera- ture and future perspectives. Cancer medicine. 2013; 2: 674-686.
11. Velho TR, Kapiteijn E, Jager MJ. New therapeutic agents in uveal melanoma. Anticancer research. 2012; 32:2591-2598.
12. Patel SP. Latest developments in the biology and management of uveal melanoma. Current oncology reports. 2013; 15:509-516.
13. Coupland SE, Lake SL, Zeschnigk M, Damato BE. Molecular pathology of uveal melanoma. Eye (Lond). 2013; 27:230-242.
14. Griewank KG, Murali R. Pathology and genetics of uveal melanoma. Pathology. 2013; 45:18-27.
15. Ohdaira H, Sekiguchi M, Miyata K, Yoshida K. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell proliferation. 2012; 45:32-38.
16. Fu LL, Zhao X, Xu HL, Wen X, Wang SY, Liu B, Bao JK, Wei YQ. Identification of microRNA-regulated autophagic pathways in plant lectin-induced cancer cell death. Cell proliferation. 2012; 45:477-485.
17. Li J, You T, Jing J. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Cell proliferation. 2014; 47:152-160.
18. Li M, Yu M, Liu C, Zhu H, He X, Peng S, Hua J. miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis. Cell proliferation. 2013; 46:223-231.
19. Zhou J, Song S, Cen J, Zhu D, Li D, Zhang Z. MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro. Oncology research. 2012; 20:197-203.
20. Wang Z, Yin B, Wang B, Ma Z, Liu W, Lv G. MicroRNA-0 promotes proliferation and invasion of peripheral nerve sheath tumor cells targeting EFNA3. Oncology research. 2014; 21:145-154.
21. Fei B, Wu H. MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. Oncology research. 2012; 20:557-564.
22. Huang J, Zhang SY, Gao YM, Liu YF, Liu YB, Zhao ZG, Yang K. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell proliferation. 2014; 47:277-286.
23. Wang SC, Lin XL, Li J, Zhang TT, Wang HY, Shi JW, Yang S, Zhao WT, Xie RY, Wei F, Qin YJ, Chen L, Yang J, Yao KT, Xiao D. MicroRNA-122 triggers mesenchymal- epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PloS one. 2014; 9:e101330.
24. Xu Y, Jin J, Liu Y, Huang Z, Deng Y, You T, Zhou T, Si J, Zhuo W. Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2. PloS one. 2014; 9:e99516.
25. Shen J, Niu W, Zhou M, Zhang H, Ma J, Wang L. MicroRNA-410 suppresses migration and invasion by targeting MDM2 in gastric cancer. PloS one. 2014; 9:e104510.
26. Lihi Ninio-Many, Hadas Grossman, Mattan Levi, Sofia Zilber, Ilan Tsarfaty, Noam Shomron, Anna Tuvar, Dana Chuderl, Salomon M Stemmer, Irit Ben-Aharon, Ruth Shalgi. MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells.Oncoscience. 2014; 1:250-261.
27. Konstantinos G. Sidiropoulos, Nicole M.A. White, Anna Bui, Qiang Ding, Peter Boulos, Georgios Pampalakis, Heba Khella, Joseph N. Samuel, Georgia Sotiropoulou, George M. Yousef. Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer. Oncoscience. 2014; 1: in press [Epub ahead of print].
28. Xiong X, Ren HZ, Li MH, Mei JH, Wen JF, Zheng CL. Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein. Pathol Oncol Res. 2011; 17:931-937.
29. Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie T, Zhang J, Peng C, Lin Y, Chen J. MicroRNA-25 regulates chemoresistance- associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget. 2014; [Epub ahead of print].
30. Yang WB, Chen PH, Hsu Ts, Fu TF, Su WC, Liaw H, Chang WC, Hung JJ. Sp1-mediated microRNA-182 expression regulates lung cancer progression. Oncotarget. 2014; 5:740-753.
31. Zhang C, Liu J, Wang X, Wu R, Lin M, Laddha SV, Yang Q, Chan CS, Feng Z. MicroRNA-339-p inhibits colorectal tumorigenesis through regulation of the MDM2/p3 signaling. Oncotarget. 2014; 5:9106-9117.
32. Hung TM, Ho CM, Liu YC, Lee JL, Liao YR, Wu YM, Ho MC, Chen CH, Lai HS, Lee PH. Up-regulation of microRNA-10b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma. PloS one. 2014; 9:e89446.
33. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75:843-854.
34. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. The Lancet Oncology. 2012; 13:e249-258.
35. Dassow H, Aigner A. MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy. Current pharmaceutical design. 2013; 19:1242-1252.
36. Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X, Qiu G. MicroRNA-10b Promotes Nucleus Pulposus Cell Proliferation through RhoC-Akt Pathway by Targeting HOXD10 in Intervetebral Disc Degeneration. PloS one. 2013; 8:e83080.
37. Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y, Liu C, Song W, Wang F, Zhang J, Shen J, Yu J. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2015; 18:43-54.
38. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 2010; 29:5761-5771.
39. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA, Hayward NK. Characterization of the Melanoma miRNAome by Deep Sequencing. PloS one. 2010; 5:e9685.
40. Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis. 2011; 32:247-253.
41. Zhao J, Kelnar K, Bader AG. In-depth analysis shows synergy between erlotinib and miR-34a. PloS one. 2014; 9:e89105.
42. Morishita A, Masaki T. miRNA in hepatocellular carcinoma. Hepatology research: the official journal of the Japan Society of Hepatology. 2014; [Epub ahead of print].
43. Liang W, Gao B, Fu P, Xu S, Qian Y, Fu Q. The miRNAs in the pathgenesis of osteosarcoma. Front Biosci (Landmark Ed). 2013; 18:788-794.
44. Worley LA, Long MD, Onken MD, Harbour JW. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res. 2008; 18:184-190.
45. Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Investigative ophthalmology & visual science. 2009; 50:1559-1565.
46. Radhakrishnan A, Badhrinarayanan N, Biswas J, Krishnakumar S. Analysis of chromosomal aberration and association of microRNAs in uveal melanoma. Molecular vision. 2009; 15:2146-2154.
47. Chen X, Wang J, Shen H, Lu J, Li C, Hu DN, Dong XD, Yan D, Tu L. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Investigative ophthalmology & visual science. 2011; 52:1193-1199.
48. Yang C, Wei W. The miRNA expression profile of the uveal melanoma. Sci China Life Sci. 2011; 54:351-358.
49. Dong F, Lou D. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. Molecular vision. 2012; 18:537-546.
50. Liu N, Sun Q, Chen J, Li J, Zeng Y, Zhai S, Li P, Wang B, Wang X. MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-kappaB1 pathway. Oncology reports. 2012; 28:961-968.
51. Chen X, He D, Dong XD, Dong F, Wang J, Wang L, Tang J, Hu DN, Yan D, Tu L. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma. Investigative ophthalmology & visual science. 2013; 54:2248-2256.
52. Larsen AC, Holst L, Kaczkowski B, Andersen MT, Manfe V, Siersma VD, Kolko M, Kiilgaard JF, Winther O, Prause JU, Gniadecki R, Heegaard S. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma. Acta Ophthalmol. 2014; 92:541-549.
53. Venza M, Dell'Aversana C, Visalli M, Altucci L, Teti D, Venza I. Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines. Tumori. 2014; 100:e4-7.
54. Li Y, Huang Q, Shi X, Jin X, Shen L, Xu X, Wei W. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1. Chinese medical journal. 2014; 127:1410-1416.
55. Achberger S, Aldrich W, Tubbs R, Crabb JW, Singh AD, Triozzi PL. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol Immunol. 2014; 58:182-186.
56. Sun Q, Cong R, Yan H, Gu H, Zeng Y, Liu N, Chen J, Wang B. Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncology reports. 2009; 22:563-567.
57. Yan D, Dong XD, Chen X, Yao S, Wang L, Wang J, Wang C, Hu DN, Qu J, Tu L. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PloS one. 2012; 7:e40967.
58. Shildkrot Y, Thomas F, Al-Hariri A, Fry CL, Haik BG, Wilson MW. Socioeconomic factors and diagnosis of uveal melanoma in the mid-southern United States. Curr Eye Res. 2011; 36:824-830.
59. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011; 118:1881-1885.
60. Damato B. Does ocular treatment of uveal melanoma influence survival? British journal of cancer. 2010; 103:285-290.
61. Augsburger JJ, Correa ZM, Shaikh AH. Effectiveness of treatments for metastatic uveal melanoma. American journal of ophthalmology. 2009; 148:119-127.
62. Liu HS, Xiao HS. MicroRNAs as potential biomarkers for gastric cancer. World journal of gastroenterology: WJG. 2014; 20:12007-12017.
63. Banaudha KK, Verma M. The role of microRNAs in the management of liver cancer. Methods Mol Biol. 2012; 863:241-251.
64. Wang J, Wang Q, Liu H, Hu B, Zhou W, Cheng Y. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. Cancer letters. 2010; 297:137-143.
65. Li X, Yang W, Lou L, Chen Y, Wu S, Ding G. microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma. Digestive diseases and sciences. 2014; 59:1099-1107.
66. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E. Circulating microRNAs in plasma of patients with gastric cancers. British journal of cancer. 2010; 102:1174-1179.